Interest in medicinal flower production tipped to drive demand for Sunshine Coast development opportunity

A Sunshine Coast property licensed to produce medicinal and therapeutic goods is being offered for sale on behalf of the landowner and MC Therapeutics.

CBRE’s Agribusiness team has been appointed to market the 16.2ha site, which is situated 80km north of the Brisbane CBD.

“The property is ideally suited to develop a medicinal plant cultivation facility without the complexity of obtaining the relevant production license,” CBRE Agribusiness Director Matt Childs said.

“The production of medicinal flowers is an emerging industry, and we expect significant interest from a range of buyer groups.”

The offering follows CBRE’s sale last year of an operational medicinal plant cultivation facility at Cressy in Tasmania on behalf of ECS Botanics. Eleven buyers vied for the site, resulting in a sale price of $3 million.

The Sunshine Coast property has historically been used for horticultural uses and is situated in a highly productive farming district which benefits from high annual rainfall, averaging 1,730 millilitres. 

A professional development plan for a custom-built cultivation facility is available, along with the MC production license, to be transferred upon approval of industry requirements.

Existing infrastructure includes mains power availability, a spring-fed irrigation dam, a fully lockable workshop/machinery shed and a horticulture igloo which was previously used to cultivate cucumbers

There are also three residences, featuring a total of seven bedrooms.